Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2006 Vol. 2
p
 
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2006 Vol. 2
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 5: Drug Delivery
 

In Vivo Tracking of Liposomes Using CT and MR Imaging

Authors:J. Zheng, J. Liu, D.A. Jaffray and C. Allen
Affilation:University of Toronto, CA
Pages:350 - 353
Keywords:liposome, computed tomography, magnetic resonance imaging, pharmacokinetics, contrast agent
Abstract:Currently, there are limited methods available for longitudinal and non-invasive in vivo assessment of the transport kinetics of carrier-based therapeutics, such as those relying on liposomes. A viable strategy to non-invasively track the carrier in vivo is to employ the same carrier loaded with contrast-enhancing agents such as iodine and gadolinium. If these agents are retained within the carrier, they may act as surrogates for therapeutic molecules and allow for non-invasive tracking of the carrier in vivo using computed tomography (CT) and magnetic resonance (MR) imaging devices. If a correlation can be found between the change in signal intensities measured with CT and/or MR and the actual agent concentration detected in vivo, then this method has the potential to be successfully adopted for non-invasive quantification of pharmacokinetics and biodistribution studies. In this way, not only can the same animal be sampled over multiple time points, avoiding animal-to-animal variations, but the total number of animals required for each study can also be drastically reduced. Specifically, this study evaluated the in vivo pharmacokinetics, in both mice and rabbits, of a liposome-based CT and MR contrast agent previously developed by our research group. Correlations were established between the iodine and gadolinium concentrations found in the rabbit plasma by HPLC and ICP assays and the signal enhancement obtained in the rabbit aorta in CT and MR using circular regions of interest over all time points. A linear relationship was found between the iodine concentration and Hounsfield Unit increase in CT, while an exponential relationship was observed between the gadolinium concentration and signal intensity increase in MR. This pilot study demonstrated the potential of employing CT and MR imaging for longitudinal in vivo mapping of contrast agent containing liposomes.
ISBN:0-9767985-7-3
Pages:893
Hardcopy:$185.00
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact